Champions Oncology, a leading player in the biotechnology industry, is headquartered in China (CN) and operates extensively across North America and Europe. Founded in 2010, the company has made significant strides in advancing personalised cancer treatment through its innovative technology platforms. Specialising in the development of patient-derived xenograft (PDX) models, Champions Oncology offers unique solutions that enable oncologists to tailor therapies based on individual tumour characteristics. This approach not only enhances treatment efficacy but also optimises patient outcomes. With a strong market position, Champions Oncology has garnered recognition for its contributions to cancer research and personalised medicine, solidifying its reputation as a trusted partner in the fight against cancer.
How does Champions Oncology's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Champions Oncology's score of 26 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Champions Oncology, headquartered in CN, has set ambitious climate commitments aimed at significantly reducing its greenhouse gas emissions. The company has committed to a 42% reduction in Scope 1 and Scope 2 emissions by 2030, using 2020 as the baseline year. This target has been validated through the Science Based Targets initiative (SBTi) and is aligned with the goal of limiting global warming to 1.5°C. While specific emissions data for the most recent year is not available, Champions Oncology's commitment to measure and reduce its Scope 3 emissions further demonstrates its dedication to comprehensive climate action. The targets are part of a streamlined validation route designed for small and medium-sized enterprises, reflecting the company's proactive approach to sustainability within the pharmaceuticals, biotechnology, and life sciences sector. Overall, Champions Oncology is taking significant steps towards reducing its carbon footprint and contributing to global climate goals.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Champions Oncology is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.